Hui Cao

1.3k total citations
51 papers, 1.0k citations indexed

About

Hui Cao is a scholar working on Molecular Biology, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui Cao has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Gastroenterology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui Cao's work include Gastrointestinal Tumor Research and Treatment (14 papers), MicroRNA in disease regulation (5 papers) and Gastrointestinal disorders and treatments (4 papers). Hui Cao is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (14 papers), MicroRNA in disease regulation (5 papers) and Gastrointestinal disorders and treatments (4 papers). Hui Cao collaborates with scholars based in China, United States and Hong Kong. Hui Cao's co-authors include Tian‐Le Xu, Ye Yu, Weiguang Li, Hualiang Jiang, Fang Yu, Zhi Chen, You Wang, Wei‐Qiang Gao, Jian Li and Helen He Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Hui Cao

46 papers receiving 1.0k citations

Peers

Hui Cao

IMMUN

ONCOL

Min Jueng Kang South Korea

Manling Zhang China

Philippe Kischel France

Shanmuga Chitipiralla United States

Joshua L. Deignan United States

Bence Szalai Hungary

Howard K. Surks United States

Ming Shao China

Sarah Song Australia

Min Jueng Kang South Korea

Hui Cao

642 ×0.9

126 ×0.6

203 ×1.5

IMMUN

137 ×1.1

ONCOL

56 ×0.5

Citations per year, relative to Hui Cao Hui Cao (= 1×) peers Min Jueng Kang

Countries citing papers authored by Hui Cao

Since Specialization

Citations

This map shows the geographic impact of Hui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cao more than expected).

Fields of papers citing papers by Hui Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cao. The network helps show where Hui Cao may publish in the future.

Co-authorship network of co-authors of Hui Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Cao. A scholar is included among the top collaborators of Hui Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Cao. Hui Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Xiaofan, Fang Guo, Jiao Xu, et al.. (2025). Babesia infection in cattle and dogs in Suizhou City, Hubei Province, China. PubMed. 4(1). 100170–100170. 1 indexed citations

Lu, Xiaojing, Yanying Shen, Yuxiang Luo, et al.. (2025). Integrated screens identify AURKB dependency in advanced gastrointestinal stromal tumors. The Journal of Experimental Medicine. 222(11).

Cao, Hui, Jun Lv, Canqing Yu, et al.. (2024). Trends of genetic contributions on epigenetic clocks and related methylation sites with aging: A population‐based adult twin study. Aging Cell. 24(3). e14403–e14403. 3 indexed citations

Heinrich, Michael C., Robin L. Jones, Suzanne George, et al.. (2023). Clinical Benefit of Avapritinib in KIT- Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies. Clinical Cancer Research. 30(4). 719–728. 4 indexed citations

Chen, Mei, et al.. (2023). Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma. Heliyon. 10(1). e23505–e23505. 2 indexed citations

Xu, Danhua, et al.. (2023). CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer. BMC Cancer. 23(1). 464–464. 10 indexed citations

Ni, Bo, Xuan He, Yeqian Zhang, et al.. (2023). Tumor-associated macrophage-derived GDNF promotes gastric cancer liver metastasis via a GFRA1-modulated autophagy flux. Cellular Oncology. 46(2). 315–330. 22 indexed citations

Cao, Hui, et al.. (2023). MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cell. Clinical and Experimental Hypertension. 45(1). 2206068–2206068. 8 indexed citations

Ni, Bo, Qing Li, Chun Zhuang, et al.. (2022). The nerve-tumour regulatory axis GDNF-GFRA1 promotes tumour dormancy, imatinib resistance and local recurrence of gastrointestinal stromal tumours by achieving autophagic flux. Cancer Letters. 535. 215639–215639. 11 indexed citations

10.

Zhuang, Chun, Bo Ni, Zizhen Zhang, et al.. (2021). Low Distribution of TIM-3+ Cytotoxic Tumor-Infiltrating Lymphocytes Predicts Poor Outcomes in Gastrointestinal Stromal Tumors. Journal of Immunology Research. 2021. 1–10. 4 indexed citations

11.

Yang, Linxi, Ming Wang, Lin Tu, et al.. (2019). [Application of imatinib plasma concentration monitoring in the whole process management of gastrointestinal stromal tumor patients].. PubMed. 22(9). 841–847. 1 indexed citations

12.

Tian, Guang-Ang, Chunchao Zhu, Xiao-Xin Zhang, et al.. (2016). CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib. Scientific Reports. 6(1). 31071–31071. 25 indexed citations

13.

Shen, Zhiyong, et al.. (2014). miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Experimental and Therapeutic Medicine. 7(6). 1757–1761. 37 indexed citations

14.

Zhou, Zhicheng, Zhongzhong Ji, You Wang, et al.. (2014). TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53. Gastroenterology. 147(5). 1043–1054. 138 indexed citations

15.

Li, Rongkun, Wenyi Zhao, Fang Fang, et al.. (2014). Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway. Journal of Cancer Research and Clinical Oncology. 141(2). 269–281. 56 indexed citations

16.

Zhao, Wenyi, Jia Xu, Ming Wang, et al.. (2014). Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome. BMC Gastroenterology. 14(1). 105–105. 8 indexed citations

17.

Yu, Zhe, Qi Fang, Xian Xiao, et al.. (2013). GABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes. PLoS ONE. 8(7). e69883–e69883. 23 indexed citations

18.

Cui, Yun, Wenyu Su, Jing Xing, et al.. (2011). MiR-29a Inhibits Cell Proliferation and Induces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer. PLoS ONE. 6(10). e25872–e25872. 85 indexed citations

19.

Yu, Ye, Zhi Chen, Weiguang Li, et al.. (2010). A Nonproton Ligand Sensor in the Acid-Sensing Ion Channel. Neuron. 68(1). 61–72. 170 indexed citations

20.

Cao, Hui, Genevieve B. Melton, Marianthi Markatou, & George Hripcsak. (2008). Use abstracted patient-specific features to assist an information-theoretic measurement to assess similarity between medical cases. Journal of Biomedical Informatics. 41(6). 882–888. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact